CZ44093A3 - L-glutamic acid derivative, process for preparing thereof and pharmaceutical preparation in which said derivative is comprised - Google Patents

L-glutamic acid derivative, process for preparing thereof and pharmaceutical preparation in which said derivative is comprised Download PDF

Info

Publication number
CZ44093A3
CZ44093A3 CZ93440A CZ44093A CZ44093A3 CZ 44093 A3 CZ44093 A3 CZ 44093A3 CZ 93440 A CZ93440 A CZ 93440A CZ 44093 A CZ44093 A CZ 44093A CZ 44093 A3 CZ44093 A3 CZ 44093A3
Authority
CZ
Czechia
Prior art keywords
amino
benzoyl
pyrrolo
glutamic acid
pyrimidin
Prior art date
Application number
CZ93440A
Other languages
Czech (cs)
English (en)
Inventor
Lynn Stacy Gossett
Chuan Shih
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CZ44093A3 publication Critical patent/CZ44093A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ93440A 1992-03-24 1993-03-18 L-glutamic acid derivative, process for preparing thereof and pharmaceutical preparation in which said derivative is comprised CZ44093A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/856,611 US5196424A (en) 1992-03-24 1992-03-24 N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids

Publications (1)

Publication Number Publication Date
CZ44093A3 true CZ44093A3 (en) 1994-02-16

Family

ID=25324069

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ93440A CZ44093A3 (en) 1992-03-24 1993-03-18 L-glutamic acid derivative, process for preparing thereof and pharmaceutical preparation in which said derivative is comprised

Country Status (18)

Country Link
US (1) US5196424A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0567223A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0625246A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR930019676A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1078235A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3542993A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9301273A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2091978A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ44093A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI931251A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT70036A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL105100A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9301544A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY131322A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO931008L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ247193A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW224098B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA931944B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457056A (en) * 1993-07-06 1995-10-10 Fiberchem, Inc. Halohydrocarbon sensing chemistry with base modifier
US6537999B2 (en) * 1996-06-06 2003-03-25 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
JP2000516961A (ja) * 1996-08-30 2000-12-19 イーライ・リリー・アンド・カンパニー 非古典的ピロロ［２，３―ｄ］ピリミジン抗葉酸物質
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8030319B2 (en) * 2005-02-10 2011-10-04 Duquesne University Of The Holy Ghost Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
CN1962658B (zh) * 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
KR20120103604A (ko) * 2009-11-06 2012-09-19 첼시 쎄라퓨틱스, 인코포레이티드 효소 저해성 화합물
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102977107B (zh) * 2012-12-25 2015-04-22 山西普德药业股份有限公司 一种培美曲塞二钠化合物及其组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59170091A (ja) * 1983-03-17 1984-09-26 Takeda Chem Ind Ltd ６−チオ−７−デアザプリン誘導体およびその製造法
DE3472258D1 (de) * 1983-03-17 1988-07-28 Takeda Chemical Industries Ltd Thiodeazapurine derivatives
EP0166726B1 (en) * 1983-12-27 1988-11-17 Sri International 10-ethyl-8,10-dideazaminopterins
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4988813A (en) * 1986-10-20 1991-01-29 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
US4882333A (en) * 1988-05-25 1989-11-21 The Trustess Of Princeton University N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
CH677140A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1988-10-11 1991-04-15 W & E Umwelttechnik Ag
KR970009225B1 (ko) * 1989-09-19 1997-06-09 데이진 가부시끼가이샤 피롤로[2,3-디] 피리미딘 유도체, 그의 제조방법 및 그것을 유효성분으로 하는 의약제제
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
FI931251A0 (fi) 1993-03-22
EP0567223A1 (en) 1993-10-27
BR9301273A (pt) 1993-09-28
NO931008D0 (no) 1993-03-19
FI931251L (fi) 1993-09-25
NO931008L (no) 1993-09-27
FI931251A7 (fi) 1993-09-25
TW224098B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-05-21
CN1078235A (zh) 1993-11-10
HU9300804D0 (en) 1993-06-28
AU3542993A (en) 1993-09-30
JPH0625246A (ja) 1994-02-01
NZ247193A (en) 1995-05-26
IL105100A0 (en) 1993-12-28
MY131322A (en) 2007-08-30
MX9301544A (es) 1994-07-29
CA2091978A1 (en) 1993-09-25
ZA931944B (en) 1994-09-18
KR930019676A (ko) 1993-10-18
US5196424A (en) 1993-03-23
HUT70036A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
CA3027014C (en) Piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
EP0802914B1 (en) Aryl- and heteroaryl- purine and pyridopyrimidine derivatives
AU2020226042B2 (en) Novel heterotricyclic derivative compound and use of same
FI109799B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-(substituoitu)-2,5-dialkyyli-7-(di- tai trisubstituoitu)fenyyli-7H-pyrrolo[2,3-d]pyrimidiinijohdannaisten valmistamiseksi
SK3542002A3 (en) Pteridinones as kinase inhibitors
KR20220118500A (ko) 치환 직쇄 스피로 유도체
KR20180015263A (ko) 신규한 하이드록시산 유도체, 이를 제조하는 방법 및 이를 함유하는 약제 조성물
BG106568A (bg) 5-(2-заместени-5-хетероциклилсулфонилпирид-3-ил)-дихидропиразоло[4,3-d]пиримидин-7-они като фосфодиестеразни инхибитори
Temple Jr et al. Synthesis of potential anticancer agents: imidazo [4, 5-c] pyridines and imidazo [4, 5-b] pyridines
HU198481B (en) Process for producing quinazoline derivatives and pharmaceutical compositions comprising same as active ingredient
EP0861253A1 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
KR102660196B1 (ko) 치환된 축합 헤테로아릴기 화합물인 키나제 억제제 및 이의 응용
KR20110039383A (ko) ｃＭＥＴ 억제제
US7781453B2 (en) Aminopyridine-derivatives
EP1390371B1 (en) Oxazolo-and furopyrimidines and their use in medicaments against tumors
CZ44093A3 (en) L-glutamic acid derivative, process for preparing thereof and pharmaceutical preparation in which said derivative is comprised
US4536575A (en) 2-Amino-4(3H)-oxopyrido[2,3-d]pyrimidino
CA2286909A1 (en) 5,7-disubstituted 4-aminopyrido¬2,3-d|pyrimidine compounds and their use as adenosine kinase inhibitors
TW201139434A (en) 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives, preparation thereof and therapeutic use thereof
US4526964A (en) 2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine
JP2024525145A (ja) がんなどの疾患の治療のための（ｒ）－ｎ－エチル－５－フルオロ－ｎ－イソプロピル－２－（（５－（２－（６－（（２－メトキシエチル）（メチル）アミノ）－２－メチルヘキサン－３－イル）－２，６－ジアザスピロ［３．４］オクタン－６－イル）－１，２，４－トリアジン－６－イル）オキシ）ベンズアミドベシル酸塩
CN111808077B (zh) 哌嗪酰胺衍生物，其制备方法及其在医药上的用途
EP0075880B1 (en) Pyrido (2,3-d) pyrimidines
US4628089A (en) Pyrido(2,3-D)pyrimidines
Gangjee et al. Synthesis and biological activity of 5, 11-methylenetetrahydro-5-deazahomofolic acid